Volume 8, Issue 1, March 2020, Page: 25-28
Evaluating Influence of Seamless Nursing for the Gastrointestinal Cancer Patients
Zhouyu Zeng, Gastric & Intestine Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Lilian Gao, Gastric & Intestine Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Xiuli Wei, Gastric & Intestine Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Lina Wu, Gastric & Intestine Department, The First Affiliated Hospital of Jinan University, Guangzhou, China
Received: Feb. 14, 2020;       Accepted: Feb. 27, 2020;       Published: Mar. 18, 2020
DOI: 10.11648/j.jctr.20200801.15      View  281      Downloads  154
Abstract
Objective: to evaluate effect of seamless nursing for complications on gastrointestinal cancer patients. Methods: 266 patients diagnosed as gastrointestinal cancer from June 2016 to March 2019. The control group and intervention group were assigned from participants after they agreed to join this study. We collected the information by different questionnaires and hospital record, the questionnaires included Self-Rating Anxiety Scale (SAS), the Self-rating depression scale (SDS) and Self-rating form of satisfaction. Result: The most of gastrointestinal cancer stage in two groups was early gastrointestinal cancer [57 (42.9%) & 55 (41.4%), p=0.023]. In SAS and SDS research, the improvement was not significant (34.22±1.12 vs 46.32±3.26, 32.38±3.01 vs 46.52±5.84), the improvement had statistical significance. In satisfaction research, the satisfaction of intervention group patients was higher (84.2% vs 81.2%). The number of people in bad level is about the similar as the number. Conclusion: The seamless nursing measure had positive influence in treatment outcome. The seamless nursing measure had better influence for the patients of gastrointestinal cancer. However, the result of improvement was not significant for the patients of gastrointestinal cancer. Besides, the seamless nursing had better influence for satisfaction on patients of gastrointestinal cancer.
Keywords
Seamless Nursing, Gastrointestinal Cancer, Satisfaction of Patients
To cite this article
Zhouyu Zeng, Lilian Gao, Xiuli Wei, Lina Wu, Evaluating Influence of Seamless Nursing for the Gastrointestinal Cancer Patients, Journal of Cancer Treatment and Research. Vol. 8, No. 1, 2020, pp. 25-28. doi: 10.11648/j.jctr.20200801.15
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Backes C, Sedaghat-Hamedani F, Frese K, Hart M, Ludwig N, Meder B, Meese E, Keller A. Bias in high-throughput analysis of miRNAs and implications for biomarker studies, Anal. Chem. 2016; 88: 2088-2095.
[2]
Valli VP, Valli C, Pfammatter T, Bauerfeind P. Life-threatening bleeding of a duodenal gastrointestinal stromal tumor in a teenager: a rare case report, Endosc. Int. 2016: E1244–E1246.
[3]
Szucs Z, Thway K, Fisher C, Bulusu R, Constantinidou A, Benson C, et al. Molecular subtypes of gastrointestinal stromal tumors and their prognostic and therapeutic implications. Future Oncol 2017; 13 (1): 93–107.
[4]
Rasheed MRHA, Tarjan G. Succinate dehydrogenase complex: an updated review. Arch. Pathol. Lab. Med 2018; 142 (12): 1564–1570.
[5]
Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, et al. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2013; 381 (9863): 295–302.
[6]
Graham DY. Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits. Gastroenterology 2015; 148 (4): 719–723.
[7]
GLOBOCAN, Estimated number of colorectal cancer new cases in 2018, worldwide, both sexes, all ages, Cancer Today, 2018.
[8]
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65 (2): 87–108.
[9]
Chen H, Liu H, Qing G. Targeting oncogenic myc as a strategy for cancer treatment. Signal Transduct Target Ther 2018; 3 (5).
[10]
Zhai FY, Wang ZH, DuSF, Zhang JG, Du WW, Popkin BM. Dynamics of the Chinese diet and the role of urbanicity, 1991-2011. Obes Rev 2016; 15 (Suppl 1): 16–26.
[11]
White D, Leach C, Sims R, Atkinson M, Cottrell D. Validation of the Hospital Anxiety and Depression Scale for use with adolescents. Br J Psychiatry 1999; 175: 452–454.
[12]
El-Rufaie O, Absood G. Validity study of the Hospital Anxiety and Depression Scale among a group of Saudi patients. Br J Psychiatry 1987; 151: 687–688.
[13]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68: 7–30.
[14]
Otutaha B, Srinivasa S, Koea J. Patient information needs in upper gastrointestinal cancer: what patients and their families want to know. ANZ J Surg 2019; 89: 20–24.
[15]
Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 2017; 67: 93–99.
[16]
Argolo DF, Hudis CA, Iyengar NM. The impact of gastrointestinal cancer on Breast cancer. Curr Oncol Rep 2018; 20: 47.
[17]
Haslam DW, James WP. gastrointestinal cancer. Lancet (London, England) 2015; 366: 1197-1209.
[18]
Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies, Bmj. 2014; 348.
Browse journals by subject